Aehr’s Record Bookings Signal Growing AI and Data Center Momentum
Amid challenges in revenue and earnings, Aehr Test Systems (NASDAQ: AEHR) has delivered a standout quarter on the bookings front, reporting $37.2 million secured in third-quarter orders. This marks not only a quarterly high but also a striking book-to-bill ratio exceeding 3.5x—a clear sign that demand for their semiconductor test solutions is ramping up, particularly in high-growth sectors like AI and data centers.
Bookings and Backlog Point Toward a Rebound
The company’s ability to convert interest into orders stands out this quarter: as of February 27, 2026, the backlog sits at $38.7 million, but including additional post-quarter bookings, the effective backlog climbs to $50.9 million. Management expects further near-term orders from a major hyperscale customer in the AI space, projecting full-year bookings on the high end of the $60 million to $80 million range previously guided. This substantial order pipeline has management confident in stronger revenue performance heading into fiscal 2027.
| Key Metric | Q3 FY2026 | Q3 FY2025 | First 9M FY2026 | First 9M FY2025 |
|---|---|---|---|---|
| Net Revenue ($M) | 10.31 | 18.31 | 31.17 | 44.88 |
| GAAP Net Loss ($M) | (3.20) | (0.64) | (8.52) | (1.01) |
| Non-GAAP Net Income (Loss) ($M) | (1.52) | 1.98 | (2.64) | 4.83 |
| Bookings ($M) | 37.20 | N/A | N/A | N/A |
| Book-to-Bill Ratio | 3.5x+ | N/A | N/A | N/A |
| Backlog ($M) (Eff. incl. post-Qtr) | 50.90 | N/A | N/A | N/A |
Order Flow Highlights AI and Silicon Photonics Growth
Aehr’s quarterly performance is driven by broad-based demand spanning wafer-level burn-in (WLBI) and package-level solutions (PLBI)—especially from hyperscale data center and AI processor customers. In particular:
- Multiple new orders for FOX-XP WLBI systems from AI processor leaders, supporting large-scale data center inference and training applications.
- New customer wins in silicon photonics, targeting high-speed fiber optic communications in hyperscale AI and cloud data centers.
- Follow-on, high-value orders from existing hyperscale and silicon photonics customers, reinforcing adoption trends for optical and AI hardware.
These trends align with increased conversations and forecasts from a wider range of semiconductor firms. Aehr’s unique WLBI and PLBI offerings are benefiting as device complexity, the need for yield assurance, and the prevalence of advanced packaging further accelerate.
Profitability Under Pressure, But Cash Position Strengthens
Despite strong bookings, Aehr’s revenue and profitability declined year-over-year. Third quarter net revenue was $10.31 million (down from $18.31 million a year ago), driving a GAAP net loss of $(3.20) million and a non-GAAP net loss of $(1.52) million. Cost management challenges, product mix shifts, and the timing of shipments contributed to these results. Yet, the balance sheet is solid: cash, cash equivalents, and restricted cash totaled $37.1 million at quarter-end—up from $31 million three months prior, bolstered in part by a recent equity issuance.
Guidance Calls for Rebound in the Back Half—Management Remains Bullish on FY27
For the second half of fiscal 2026 (ending May 29), Aehr reiterated its revenue guidance of $25 million to $30 million and expects to narrow its non-GAAP net loss per share to between $(0.09) and $(0.05). Management is optimistic about entering fiscal 2027 with a robust backlog, citing a “clear path to sustained long-term growth” anchored by expanding AI, silicon photonics, and power semiconductor markets.
Table: Fiscal 2H 2026 Guidance
| Metric | Guidance Range |
|---|---|
| Revenue ($M) | 25 – 30 |
| Non-GAAP Net Loss/Share | $(0.09) to $(0.05) |
| Bookings for 2H FY2026 ($M) | 60 – 80 (High end expected) |
Takeaway: Order Trends Signal Underlying Strength Despite Revenue Dip
The headline takeaway: Aehr’s order books are swelling as AI and next-generation data center needs intensify, even as near-term revenues soften following a major product transition. Investors tracking semiconductor capital equipment cycles may view this combination—a high book-to-bill, rising backlog, and robust cash reserves—as an early indicator of demand translating to top-line growth in the coming quarters.
As always, forward-looking statements are subject to execution risks and customer program timelines. But with large-scale production ramps planned by leading AI and photonics customers, Aehr’s momentum in next-gen semiconductor testing solutions is set to be closely watched as the fiscal year closes. For those seeking signals of where AI-driven semiconductor demand may be heading next, Aehr’s latest results send a message: the order book is full, even if the top line needs time to catch up.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI